Sartorius Aktiengesellschaft (LON:0NIQ)

Market Cap	12.06B -16.0%
Revenue (ttm)	3.07B +5.8%
Net Income	116.61M +72.2%
EPS	n/a
Shares Out	n/a
PE Ratio	103.42
Forward PE	35.51
Dividend	0.61 (0.33%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	904
Open	179.40
Previous Close	180.00
Day's Range	179.40 - 180.60
52-Week Range	131.40 - 208.00
Beta	1.52
RSI	38.19
Earnings Date	Feb 3, 2026

About LON:0NIQ

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1870
• Employees: 13,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NIQ

Financial Performance

In 2024, LON:0NIQ's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.

Financial numbers in EUR